Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro.

Ibrahim MM, Sun MZ, Huang Y, Jun M, Jin Y, Yue D, Jiasheng W, Zhang J, Qazi AS, Sagoe K, Tang J.

Biomed Pharmacother. 2013 May;67(4):285-91. doi: 10.1016/j.biopha.2013.02.005. Epub 2013 Feb 27.

PMID:
23582794
2.

Annexin A7 gene is an important factor in the lymphatic metastasis of tumors.

Jin YL, Wang ZQ, Qu H, Wang HX, Ibrahim MM, Zhang J, Huang YH, Wu J, Bai LL, Wang XY, Meng JY, Tang JW.

Biomed Pharmacother. 2013 May;67(4):251-9. doi: 10.1016/j.biopha.2012.11.006. Epub 2012 Dec 30.

PMID:
23540285
3.

Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.

Xu D, He XX, Chang Y, Sun SZ, Xu CR, Lin JS.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2367-73. doi: 10.5754/hge12458.

PMID:
22773266
4.

Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo.

Xiong Z, Lü MH, Fan YH, Cao YL, Hu CJ, Wu YY, Wang SM, Luo G, Fang DC, Li C, Yang SM.

Int J Oncol. 2012 May;40(5):1601-9. doi: 10.3892/ijo.2012.1338. Epub 2012 Jan 20.

PMID:
22267022
5.

Inhibition of annexin A7 gene and protein induces the apotosis and decreases the invasion, migration of the hepatocarcinoma cell line.

Huang Y, Wang Q, Du Y, Bai L, Jin F, Zhang J, Fan S, Wang H, Song L, Gao Y, Wang X, Tang J.

Biomed Pharmacother. 2014 Sep;68(7):819-24. doi: 10.1016/j.biopha.2014.07.001. Epub 2014 Jul 11.

PMID:
25070395
6.

ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.

Zheng L, Liang P, Li J, Huang XB, Liu SC, Zhao HZ, Han KQ, Wang Z.

PLoS One. 2012;7(9):e45412. doi: 10.1371/journal.pone.0045412. Epub 2012 Sep 25.

7.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109. Epub 2007 Jul 26.

PMID:
17698398
8.

[The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].

Zhang Y, Hu MY, Chen BH, Wang ZJ, Zha XL, Liu KD.

Zhonghua Yi Xue Za Zhi. 2006 Feb 28;86(8):530-5. Chinese.

PMID:
16681881
9.

MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.

Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, Luo XZ, Wang D.

J Gastroenterol Hepatol. 2010 Jan;25(1):164-71. doi: 10.1111/j.1440-1746.2009.05971.x. Epub 2009 Sep 27.

PMID:
19793168
10.

Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells.

Yue Y, Shao Y, Luo Q, Shi L, Wang Z.

Biomed Res Int. 2013;2013:434561. doi: 10.1155/2013/434561. Epub 2013 Jul 14. Retraction in: Biomed Res Int. 2014;2014:308263.

11.

Guanine nucleotide-binding protein subunit beta-2-like 1, a new Annexin A7 interacting protein.

Du Y, Meng J, Huang Y, Wu J, Wang B, Ibrahim MM, Tang J.

Biochem Biophys Res Commun. 2014 Feb 28;445(1):58-63. doi: 10.1016/j.bbrc.2014.01.119. Epub 2014 Feb 1.

PMID:
24491534
12.

MDA-7/IL-24 suppresses tumor adhesion and invasive potential in hepatocellular carcinoma cell lines.

Huo W, Li ZM, Zhu XM, Bao YM, An LJ.

Oncol Rep. 2013 Aug;30(2):986-92. doi: 10.3892/or.2013.2507. Epub 2013 May 29.

PMID:
23722307
13.
14.

[Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].

Yu DD, Yao M, Chen J, Wang L, Yan MJ, Gu X, Qiu LW, Dong ZZ, Yao DF, Lu SL.

Zhonghua Gan Zang Bing Za Zhi. 2013 Jun;21(6):452-8. doi: 10.3760/cma.j.issn.1007-3418.2013.06.016. Chinese.

PMID:
24034848
15.

[Interferon-induced transmembrane protein 3 knock-down inhibits proliferation and invasion of hepatocellular carcinoma HepG2 cells in vitro].

Wu RS, Wu LQ, Li KH, Li EL, Feng Q, Zhang JL.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb;36(2):244-9. Chinese.

PMID:
26922024
16.

Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.

Zhang HJ, Yao DF, Yao M, Huang H, Wang L, Yan MJ, Yan XD, Gu X, Wu W, Lu SL.

World J Gastroenterol. 2013 Jun 28;19(24):3792-801. doi: 10.3748/wjg.v19.i24.3792.

17.

Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro.

Xu M, Wang Y, Chen L, Pan B, Chen F, Fang Y, Yu Z, Chen G.

Gene. 2014 Feb 15;536(1):84-9. doi: 10.1016/j.gene.2013.11.075. Epub 2013 Dec 12.

PMID:
24334120
18.

The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.

Li H, Fang L, Xiao X, Shen L.

Bull Cancer. 2012 Mar 1;99(3):E26-33. doi: 10.1684/bdc.2011.1538.

19.

Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.

Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, Zhang JP.

Chin Med J (Engl). 2011 Nov;124(22):3794-9.

PMID:
22340243
20.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

Supplemental Content

Support Center